Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39120719 | PubTator, text mining | PubMed |
| Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment. | Transl Cancer Res | 2024 | 39697708 | PubTator, text mining | PubMed |
| Roles of Copper Transport Systems Members in Breast Cancer. | Cancer Med | 2024 | 39676279 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related genes in septic shock based on bioinformatic analysis. | PLoS One | 2024 | 39652607 | PubTator, text mining | PubMed |
| Role of SLC31A1 in prognosis and immune infiltration in breast cancer: a novel insight. | Int J Clin Exp Pathol | 2024 | 39544714 | PubTator, text mining | PubMed |
| Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome. | Medicine (Baltimore) | 2024 | 39470566 | PubTator, text mining | PubMed |
| Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer. | Sci Rep | 2024 | 39448672 | PubTator, text mining | PubMed |
| Retraction Note: MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cells. | Cytotechnology | 2024 | 39435414 | PubTator, text mining | PubMed |
| Potential pathogenic roles of ferroptosis and cuproptosis in cadmium-induced or exacerbated cardiovascular complications in individuals with diabetes. | Front Endocrinol (Lausanne) | 2024 | 39415790 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis. | Eur J Med Res | 2024 | 39396083 | PubTator, text mining | PubMed |
| Copper metabolism-related signature for prognosis prediction and MMP13 served as malignant factor for breast cancer. | Heliyon | 2024 | 39315182 | PubTator, text mining | PubMed |
| Molecular characterization, immunocorrelation analysis, WGCNA analysis and machine learning modeling of genes associated with copper death subtypes of laryngeal cancer. | Technol Health Care | 2024 | 39302398 | PubTator, text mining | PubMed |
| Blocking lactate regulation of the Grhl2/SLC31A1 axis inhibits trophoblast cuproptosis and preeclampsia development. | J Assist Reprod Genet | 2024 | 39287710 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals copper transporters as promising potential targets. | Heliyon | 2024 | 39281483 | PubTator, text mining | PubMed |
| Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper. | Metallomics | 2024 | 39251386 | PubTator, text mining | PubMed |
| Tracking Disordered Extracellular Domains of Membrane Proteins in the Cell with Cu(II)-Based Spin Labels. | J Phys Chem B | 2024 | 39231533 | PubTator, text mining | PubMed |
| Identification and Verification of the Oxidative Stress-Related Signature Markers for Intracranial Aneurysm-Applied Bioinformatics. | Front Biosci (Landmark Ed) | 2024 | 39206894 | PubTator, text mining | PubMed |
| Endogenous retrovirus ERV-DC8 highly integrated in domestic cat populations is a replication-competent provirus. | Biochem Biophys Res Commun | 2024 | 39153451 | PubTator, text mining | PubMed |
| Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper-Dependent Cytotoxic Approach. | Chem Biol Drug Des | 2024 | 39147940 | PubTator, text mining | PubMed |
| ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner. | Life Sci | 2024 | 39147318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=8